InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Discover the detailed record of transactions filed by Wagner Kristie Ann, Vice-Présidente, Finances et Comptabilité Principale. Director active across 1 company, notably Entasis Therapeutics Holdings Inc.. In total, 2 reports have been logged. Activity tracked since 24 February 2022. The latest transaction was filed on 24 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Kristie Ann Wagner serves as Vice President, Principal Finance and Accounting Officer at Entasis Therapeutics Holdings Inc. She is responsible for overseeing financial and accounting operations. Kristie plays a key role in managing financial resources and ensuring compliance with accounting standards. Her expertise in finance is essential to support Entasis Therapeutics Holdings Inc.'s financial strategy.